Core Viewpoint - The State Administration for Market Regulation has approved a pilot program for cross-regional review of medical device advertisements in the Yangtze River Delta region, aiming to streamline the approval process and enhance the business environment [1] Group 1: Pilot Program Details - The pilot program involves the market regulation bureaus of Shanghai, Jiangsu, Zhejiang, and Anhui provinces [1] - It focuses on addressing bottlenecks in the review of medical device advertisements through innovative approval models [1] - The program allows for "one application, one review, one license issued" within the Yangtze River Delta region for qualifying medical device advertisement review applications [1] Group 2: Objectives and Benefits - The initiative aims to reduce the administrative burden and costs for advertisement applicants [1] - It seeks to continuously optimize the business environment and improve service efficiency for enterprises [1] - The program is designed to explore and accumulate replicable and promotable experiences for reforming and improving advertisement review management systems [1]